Table 2.

Response rates to chronic hepatitis B treatments [17–20]

24th week	TDF	ETV	3TC	LAM	LdT	TDF	ETV	3TC	LAM	LdT
<300	84.8	84.8	73.0	71.0	80.0	48.9	37.0	34.0	32.0	45.0
300–104	9.7	9.7	15.0	20.0	15.0	32.5	40.0	26.0	31.0	31.0
104–105	2.7	2.7	3.6	2.7	1.5	8.9	11.0	12.0	11.1	7.2
105–106	0.2	0.2	1.5	1.1	0.6	0.8	1.0	5.0	4.6	3.0
>106	2.7	2.7	6.9	5.2	2.9	8.9	11.0	23.0	21.3	13.8
48th week
<300	93.2	93.3	75.6	71.4	88.3	76.1	69.1	39.8	40.4	60.0
300–104	4.2	4.1	12.5	18.4	8.0	19.1	24.7	18.2	28.1	21.5
104–105	1.6	1.6	5.1	7.5	3.3	3.4	4.4	11.7	18.1	13.8
105–106	0.3	0.3	2.0	0.8	0.1	0.5	0.6	9.3	4.1	1.4
>106	0.6	0.6	4.8	1.9	0.3	0.9	1.2	21.0	9.3	3.3

Values are expressed as %